Curis
CRIS
#11081
Rank
C$0.94 M
Marketcap
C$0.49
Share price
-17.89%
Change (1 day)
-78.38%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of March 2026 : C$1.87 Million

According to Curis's latest financial reports the company's total debt is C$1.87 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$2.21 M-47.73%
2024-12-31C$4.23 M14.39%
2023-12-31C$3.7 M-30.7%
2022-12-31C$5.34 M-16.74%
2021-12-31C$6.42 M-34.25%
2020-12-31C$9.76 M4406.14%
2019-12-31C$0.21 M-99.55%
2018-12-31C$48.33 M-7.48%
2017-12-31C$52.24 M95.76%
2016-12-31C$26.68 M-20.38%
2015-12-31C$33.52 M2.07%
2014-12-31C$32.84 M0.97%
2013-12-31C$32.52 M9.62%
2012-12-31C$29.67 M
2008-12-31N/A-100%
2007-12-31C$0.4 M-82.52%
2006-12-31C$2.3 M-66.05%
2005-12-31C$6.78 M-17.49%
2004-12-31C$8.22 M12.15%
2003-12-31C$7.33 M-62.58%
2002-12-31C$19.6 M16.47%
2001-12-31C$16.83 M83.41%
2000-12-31C$9.17 M369.09%
1999-12-31C$1.95 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
C$89.33 B 4,766,541.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$65.07 B 3,472,450.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$40.42 M 2,057.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$0.23 B 12,580.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$2.67 M 42.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$11.93 M 536.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.80 B 42,802.02%๐Ÿ‡บ๐Ÿ‡ธ USA